SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-003014
Filing Date
2023-02-22
Accepted
2023-02-22 17:05:45
Documents
2
Period of Report
2023-02-14

Document Format Files

Seq Description Document Type Size
1 form3-02222023_100237.html 3  
1 form3-02222023_100237.xml 3 2382
2 ex24-02222023_100238.htm EX-24 6318
  Complete submission text file 0001415889-23-003014.txt   10066
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address
Grimaud Brett A. (Reporting) CIK: 0001966698 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36033 | Film No.: 23654434